Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can be repurposed and used for faster treatment of serious terminal...
Read More
Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s no secret that drug prices are a controversial issue. Just...
Read More
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. I recently wrote about five technologies that are shaping the future of healthcare. One of these...
Read More
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus,...
Read More
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus,...
Read More
Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in...
Read More
